Table 3. Perceptions of hepatitis B among 728 study participants in Selangor, Malaysia, 2016.

Construct domain	Strongly disagree n (%)	Disagree n (%)	Somewhat disagree n (%)	Neither agree or disagree n (%)	Somewhat agree n (%)	Agree n (%)	Strongly agree n (%)
Cues to action
CA1	25 (3.4)	24 (3.3)	35 (4.8)	73 (10.0)	113 (15.5)	163 (22.4)	295 (40.5)
CA2	41 (5.6)	52 (7.1)	64 (8.8)	98 (13.5)	100 (13.7)	154 (21.2)	219 (30.1)
CA3	18 (2.5)	29 (4.0)	32 (4.4)	54 (7.4)	110 (15.1)	145 (19.9)	340 (46.7)
Perceived barriers
PB1	206 (28.3)	190 (26.1)	104 (14.3)	114 (15.6)	60 (8.2)	28 (3.8)	26 (3.6)
PB2	286 (39.2)	133(18.2)	82 (11.2)	100 (13.7)	41 (5.6)	39 (5.3)	47 (6.4)
PB3	250 (34.3)	145 (19.9)	79 (10.8)	87 (11.9)	70 (9.6)	49 (6.7)	48 (6.6)
Perceived benefit
PBE1	15 (2.1)	11 (1.5)	20 (2.7)	38 (5.2)	124 (17.0)	205 (28.2)	315 (43.3)
PBE2	14 (1.9)	15 (2.1)	27 (3.7)	49 (6.7)	132 (18.1)	233 (32.0)	258 (35.4)
PBE3	18 (2.5)	13 (1.8)	22 (3)	81 (11.1)	153 (21)	199 (27.3)	242 (33.2)
PBE4	23 (3.2)	27 (3.7)	27 (3.7)	66 (9.1)	125 (17.2)	216 (29.7)	244 (33.5)
PBE5	13 (1.8)	14 (1.9)	28 (3.8)	41 (5.6)	125 (17.2)	219 (30.1)	288 (39.6)
Perceived severity
PSE1	16 (2.2)	25 (3.4)	48 (6.6)	45 (6.2)	93 (12.8)	144 (19.8)	357 (49.0)
PSE2	28 (3.8)	38 (5.2)	48 (6.6)	52 (7.1)	91 (12.5)	173 (23.7)	298 (40.9)
PSE3	18 (2.5)	16 (2.2)	46 (6.3)	65 (8.9)	89 (12.2)	138 (18.9)	356 (48.8)
PSE4	29 (4.0)	54 (7.4)	47 (6.4)	71 (9.7)	115 (15.8)	153 (21.0)	259 (35.5)
Perceived susceptibility
PSU1	79 (10.8)	92 (12.6)	95 (13)	164 (22.5)	98 (13.4)	126 (17.3)	74 (10.2)
PSU2	88 (12.1)	94 (12.9)	97 (13.3)	158 (21.7)	106 (14.5)	116 (15.9)	69 (9.5)
PSU3	152 (20.9)	123 (16.9)	99 (13.6)	75 (10.3)	105 (14.4)	82 (11.2)	92 (12.6)